Traws Pharma (TRAW) Invested Capital (2016 - 2025)
Historic Invested Capital for Traws Pharma (TRAW) over the last 14 years, with Q3 2025 value amounting to $4.5 million.
- Traws Pharma's Invested Capital rose 32356.12% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year increase of 32356.12%. This contributed to the annual value of -$31.6 million for FY2024, which is 39638.31% down from last year.
- Per Traws Pharma's latest filing, its Invested Capital stood at $4.5 million for Q3 2025, which was up 32356.12% from $8.3 million recorded in Q2 2025.
- Traws Pharma's Invested Capital's 5-year high stood at $49.7 million during Q3 2021, with a 5-year trough of -$105.5 million in Q2 2024.
- In the last 5 years, Traws Pharma's Invested Capital had a median value of $18.9 million in 2023 and averaged $13.7 million.
- Per our database at Business Quant, Traws Pharma's Invested Capital surged by 64688.26% in 2021 and then crashed by 65836.6% in 2024.
- Over the past 5 years, Traws Pharma's Invested Capital (Quarter) stood at $46.1 million in 2021, then crashed by 38.62% to $28.3 million in 2022, then plummeted by 62.3% to $10.7 million in 2023, then crashed by 396.38% to -$31.6 million in 2024, then surged by 114.37% to $4.5 million in 2025.
- Its Invested Capital stands at $4.5 million for Q3 2025, versus $8.3 million for Q2 2025 and $6.0 million for Q1 2025.